​
​

Cara Therapeutics Ownership | Who Owns Cara Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Cara Therapeutics Ownership Summary

Cara Therapeutics is owned by 32.40% institutional investors, 15.74% insiders, and 51.86% retail investors. Vanguard group is the largest institutional shareholder, holding 4.12% of CARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.47% of its assets in Cara Therapeutics shares.

CARA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCara Therapeutics32.40%15.74%51.86%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.35M2.47%-
Disciplined Growth - Small Cap Growth811.50K1.48%811.50K
Vanguard Institutional Extnd Mkt Idx Tr645.75K1.18%-
Fidelity Extended Market Index267.47K0.49%190.84K
Vanguard Health Care ETF164.37K0.30%-408.00
Fidelity Enhanced Small Cap ETF155.03K0.28%155.03K
NT R2000 Value Index Fund - NL125.06K0.23%-20.83K
NT R2000 Index Fund - NL121.34K0.22%-2.41K
NT R2000 Index Fund - DC - NL - 296.02K0.18%-2.26K
Northern Trust Russell 2000 Value Index95.20K0.17%2.40K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 04, 2024Posner Christopher PRESIDENT AND CEOSell$1.06K
Aug 01, 2024Posner Christopher PRESIDENT AND CEOSell$1.45K
May 02, 2024Posner Christopher PRESIDENT AND CEOSell$2.95K
Apr 05, 2024Goncalves Joana CHIEF MEDICAL OFFICERSell$2.28K
Apr 05, 2024Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.Sell$2.28K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2-3
2024 Q1-5
2023 Q4-1

CARA Ownership FAQ

Who Owns Cara Therapeutics?

Cara Therapeutics shareholders are primarily institutional investors at 32.40%, followed by 15.74% insiders and 51.86% retail investors. The average institutional ownership in Cara Therapeutics's industry, Biotech Stocks , is 45.35%, which Cara Therapeutics falls below.

Who owns the most shares of Cara Therapeutics?

Cara Therapeutics’s largest shareholders are Vanguard group (2.25M shares, 4.12%), Disciplined growth investors inc /mn (1.94M shares, 3.55%), and Chescapmanager (1.7M shares, 3.12%). Together, they hold 10.79% of Cara Therapeutics’s total shares outstanding.

Does Blackrock own Cara Therapeutics?

Yes, BlackRock owns 1.36% of Cara Therapeutics, totaling 744.71K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 192.13K$. In the last quarter, BlackRock decreased its holdings by -2.677M shares, a -78.23% change.

Who is Cara Therapeutics’s biggest shareholder by percentage of total assets invested?

Chescapmanager is Cara Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 1.7M Cara Therapeutics shares, valued at 439.14K$.

Who is the top mutual fund holder of Cara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cara Therapeutics shares, with 2.47% of its total shares outstanding invested in 1.35M Cara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools